Sant Cugat del Vallès
Grifols confident in stabilising albumin in the second half of the year
Grifols expects albumin revenue to stabilise in the second half of 2026 after a 14% drop in the first half due to price adjustments in China.
Nacho Abia
Latest nacho abia news
4 articles
Sant Cugat del Vallès
Grifols reports €227 million profit by June, up 28.7%, and improves its financial position
Grifols earned €227 million in the first half of 2026, a 28.7% increase, and refinanced its 2027 debt under better conditions.
Sant Cugat del Vallès
Grifols reports €227 million profit in the first half driven by immunoglobulins
Grifols reports a €227 million profit in the first half, up 28.7%, driven by immunoglobulins and operational recovery.
Sant Cugat del Vallès
Grifols reports a 28.7% increase in profit for the first half, reaching 227 million, despite a 3% drop in revenue
Grifols earns 227 million in the first half, a 28.7% increase, despite a 3% revenue drop due to currency effects. The Catalan pharmaceutical improves its EBITDA by 2%.